Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002480 · ClinicalTrials.gov registry record · Phase 1
Radiation Therapy in Treating Patients With Prostate Cancer
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00002480: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00002480 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002480, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiation therapy may be an effective treatment for prostate cancer. PURPOSE: Phase I trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III prostate cancer.
Interventions
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1991-02 |
| Est. Completion | 2005-08 |
| Phase | Phase 1 |
What the finished NCT00002480 record still lists
NCT00002480 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which radiation therapy is the first listed.
NCT00002480 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002480 about?
NCT00002480 is a clinical study titled "Radiation Therapy in Treating Patients With Prostate Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiation therapy may be an effective treatment for prostate cancer. PURPOSE: Phase I trial to study the effectiveness of radiation therapy in treating patients who have stage II or stage III prostate cancer.
What is the current status of trial NCT00002480?
This trial is currently completed. It is a Phase 1 study. The study started on 1991-02. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00002480?
The interventions under investigation include: radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00002480?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia